Welcome to CDC Stacks | Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection - 21630 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection
  • Published Date:
    Jul 2013
  • Source:
    Emerg Infect Dis. 19(7):1138-1141.
Filetype[PDF - 410.62 KB]


No Related Documents.
You May Also Like:
  1. Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010–2011
    Personal Author:
    Dobler, Claudia C.; Korver, Sarah; Batbayar, Ochirbat; Nyamdulam, Batiargal; Oyuntsetseg, Sodnomdarjaa; Tsolmon, Bold; Surmaajav, Bazarragchaa; Bayarjargal, Byambaa; Marais, Ben J.;
    Published:
    Aug 2015
    Source:
    Emerg Infect Dis. 21(8):1451-1454.
    Description:
    In Ulaanbaatar, Mongolia, multidrug-resistant tuberculosis (MDR TB) was diagnosed for more than a third of new sputum smear-positive tuberculosis patients for whom treatment had failed. This finding suggests a significant risk for community-acquired ...
    File Type:
    Filetype[PDF - 1.00 MB]
  2. Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment
    Personal Author:
    He, Guang Xue; Xie, Yan Guang; Wang, Li Xia; Borgdorff, Martien W.; van der Werf, Marieke J.; Fan, Ji Huan; Yan, Xing Lu; Li, Fa Bin; Zhang, Xue Zhi; Zhao, Yan Lin; van den Hof, Susan;
    Published:
    May 24 2010
    Source:
    PLoS One. 5(5).
    Description:
    Background : In 2004, an anti-tuberculosis (TB) drug resistance survey in Heilongjiang province, China, enrolled 1574 (79%) new and 421 (21%) retreatment patients. Multi-drug resistant (MDR) TB was detected in 7.2% of new and 30.4% of retreatment pat...
    File Type:
  3. Multidrug-Resistant Tuberculosis
    Personal Author:
    D’Ambrosio, Lia; Centis, Rosella; Migliori, Giovanni B.;
    Published:
    Nov 29 2012
    Source:
    N Engl J Med. 367(22):2154-2156.
    File Type:
    Filetype[PDF - 32.34 KB]
  4. Characteristics of multidrug-resistant tuberculosis in Namibia
    Personal Author:
    Ricks, Philip M; Mavhunga, Farai; Modi, Surbhi; Indongo, Rosalia; Zezai, Abbas; Lambert, Lauren A; DeLuca, Nick; Krashin, Jamie S; Nakashima, Allyn K; Holtz, Timothy H;
    Published:
    Dec 29 2012
    Source:
    BMC Infect Dis. 2012; 12:385.
    Description:
    Background : To describe the epidemiology and possible risk factors for the development of multidrug-resistant tuberculosis (MDR-TB) in Namibia. : Methods : Using medical records and patient questionnaires, we conducted a case-control study among pat...
    File Type:
    Filetype[PDF - 198.21 KB]
  5. Multidrug-Resistant Tuberculosis in Europe, 2010–2011
    Personal Author:
    Günther, Gunar; van Leth, Frank; Alexandru, Sofia; Altet, Neus; Avsar, Korkut; Bang, Didi; Barbuta, Raisa; Bothamley, Graham; Ciobanu, Ana; Crudu, Valeriu; Davilovits, Manfred; Dedicoat, Martin; Duarte, Raquel; Gualano, Gina; Kunst, Heinke; de Lange, Wiel; Leimane, Vaira; Magis-Escurra, Cecile; McLaughlin, Anne-Marie; Muylle, Inge; Polcová, Veronika; Pontali, Emanuele; Popa, Christina; Rumetshofer, Rudolf; Skrahina, Alena; Solodovnikova, Varvara; Spinu, Victor; Tiberi, Simon; Viiklepp, Piret; Lange, Christoph;
    Corporate Author:
    TBNET
    Published:
    Mar 2015
    Source:
    Emerg Infect Dis. 21(3):409-416.
    Description:
    Drug-resistant Mycobacterium tuberculosis is challenging elimination of tuberculosis (TB). We evaluated risk factors for TB and levels of second-line drug resistance in M. tuberculosis in patients in Europe with multidrug-resistant (MDR) TB. A total ...
    File Type:
    Filetype[PDF - 495.89 KB]